BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12747840)

  • 1. Analysis of Myc bound loci identified by CpG island arrays shows that Max is essential for Myc-dependent repression.
    Mao DY; Watson JD; Yan PS; Barsyte-Lovejoy D; Khosravi F; Wong WW; Farnham PJ; Huang TH; Penn LZ
    Curr Biol; 2003 May; 13(10):882-6. PubMed ID: 12747840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes.
    Gartel AL; Shchors K
    Exp Cell Res; 2003 Feb; 283(1):17-21. PubMed ID: 12565816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo.
    James L; Eisenman RN
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10429-34. PubMed ID: 12149476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordinated regulation of Myc trans-activation targets by Polycomb and the Trithorax group protein Ash1.
    Goodliffe JM; Cole MD; Wieschaus E
    BMC Mol Biol; 2007 May; 8():40. PubMed ID: 17519021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max.
    Gu W; Cechova K; Tassi V; Dalla-Favera R
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2935-9. PubMed ID: 8385351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells.
    Xu D; Popov N; Hou M; Wang Q; Björkholm M; Gruber A; Menkel AR; Henriksson M
    Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3826-31. PubMed ID: 11274400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mnt-Max to Myc-Max complex switching regulates cell cycle entry.
    Walker W; Zhou ZQ; Ota S; Wynshaw-Boris A; Hurlin PJ
    J Cell Biol; 2005 May; 169(3):405-13. PubMed ID: 15866886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants.
    Mukherjee B; Morgenbesser SD; DePinho RA
    Genes Dev; 1992 Aug; 6(8):1480-92. PubMed ID: 1644290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDC6 interacts with c-Myc to inhibit E-box-dependent transcription by abrogating c-Myc/Max complex.
    Takayama M; Taira T; Iguchi-Ariga SM; Ariga H
    FEBS Lett; 2000 Jul; 477(1-2):43-8. PubMed ID: 10899308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity.
    Ayer DE; Kretzner L; Eisenman RN
    Cell; 1993 Jan; 72(2):211-22. PubMed ID: 8425218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional control of DNA replication licensing by Myc.
    Valovka T; Schönfeld M; Raffeiner P; Breuker K; Dunzendorfer-Matt T; Hartl M; Bister K
    Sci Rep; 2013 Dec; 3():3444. PubMed ID: 24309437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of transcriptional repression by Myc.
    Kleine-Kohlbrecher D; Adhikary S; Eilers M
    Curr Top Microbiol Immunol; 2006; 302():51-62. PubMed ID: 16620025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Myc: Max complex formation and its potential role in cell proliferation.
    Blackwood EM; Eisenman RN
    Tohoku J Exp Med; 1992 Oct; 168(2):195-202. PubMed ID: 1306304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromatin dynamics at the hTERT promoter during transcriptional activation and repression by c-Myc and Mnt in Xenopus leavis oocytes.
    Wahlström T; Belikov S; Arsenian Henriksson M
    Exp Cell Res; 2013 Dec; 319(20):3160-9. PubMed ID: 23860446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA binding by the Myc oncoproteins.
    Kato GJ; Wechsler DS; Dang CV
    Cancer Treat Res; 1992; 63():313-25. PubMed ID: 1363364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).
    Kyo S; Takakura M; Taira T; Kanaya T; Itoh H; Yutsudo M; Ariga H; Inoue M
    Nucleic Acids Res; 2000 Feb; 28(3):669-77. PubMed ID: 10637317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites.
    Hurlin PJ; Quéva C; Eisenman RN
    Genes Dev; 1997 Jan; 11(1):44-58. PubMed ID: 9000049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.
    Blackwood EM; Eisenman RN
    Science; 1991 Mar; 251(4998):1211-7. PubMed ID: 2006410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.
    Marchetti A; Abril-Marti M; Illi B; Cesareni G; Nasi S
    J Mol Biol; 1995 May; 248(3):541-50. PubMed ID: 7752223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel targets of MYC whose transcription requires the essential MbII domain.
    Zhang XY; DeSalle LM; McMahon SB
    Cell Cycle; 2006 Feb; 5(3):238-41. PubMed ID: 16434883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.